Covered recipient · General Payments record
JULIE A GOODMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,151.81
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.24 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $213.87 | 12 |
| Novo Nordisk AS | $47.65 | 3 |
| Currax Pharmaceuticals LLC | $27.64 | 2 |
| Abbott Laboratories | $27.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.08 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125104318 | CMS |
| Currax Pharmaceuticals LLC | $13.21 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089522482 | CMS |
| Currax Pharmaceuticals LLC | $14.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089522484 | CMS |
| Lilly USA, LLC | $14.35 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135717852 | CMS |
| Lilly USA, LLC | $0.97 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731248 | CMS |
| Lilly USA, LLC | $11.44 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135717850 | CMS |
| Lilly USA, LLC | $22.50 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731250 | CMS |
| Lilly USA, LLC | $15.69 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135647569 | CMS |
| Lilly USA, LLC | $14.86 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135721117 | CMS |
| Lilly USA, LLC | $16.86 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135729341 | CMS |
| Lilly USA, LLC | $31.39 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731246 | CMS |
| Lilly USA, LLC | $26.40 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135702863 | CMS |
| Lilly USA, LLC | $16.70 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135729339 | CMS |
| Lilly USA, LLC | $25.67 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135662035 | CMS |
| Lilly USA, LLC | $17.04 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135729343 | CMS |
| Novo Nordisk Inc | $16.44 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100651851 | CMS |
| Novo Nordisk Inc | $16.05 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100492207 | CMS |
| Novo Nordisk Inc | $15.16 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100317486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.